Meitav Dash Investments LTD Protalix Bio Therapeutics, Inc. Transaction History

Meitav Dash Investments LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$1.37 - $2.16 $205 - $324	-150 Reduced 0.06%	244,332 $513,000
Q4 2022 Feb 06, 2023	BUY	$1.0 - $1.37 $150 - $205	150 Added 0.06%	244,482 $334,000
Q1 2022 May 09, 2022	BUY	$0.81 - $1.17 $197,908 - $285,868	244,332 New	244,332 $257,000
Q4 2021 Feb 08, 2022	SELL	$0.81 - $1.33 $197,908 - $324,961	-244,332 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$1.86 - $6.22 $454,457 - $1.52 Million	244,332 New	244,332 $467,000

3.58M

61.1K

36.2K

Ticker PLX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,753,400
Market Cap $87.1M
Description
Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...

Get notified when there are updates to the investment portfolio of Meitav Dash Investments LTD, based on Form 13F filings with the SEC.

Stay updated on Meitav Dash Investments LTD with notifications on news.